Pharmacokinetic and pharmacodynamic drug-drug interactions between evogliptin and empagliflozin or dapagliflozin in healthy male volunteers

• मुख्य लेखकों: Dasohm Kim (लेखक), Minkyu Choi (लेखक), Byung Hak Jin (लेखक), Taegon Hong (लेखक), Choon Ok Kim (लेखक), Byung Won Yoo (लेखक), Min Soo Park (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Wiley, 2023-08-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract Evogliptin (EV) is a novel dipeptidyl peptidase‐4 inhibitor (DPP4i) for glycemic control in patients with type 2 diabetes mellitus (T2DM). This study evaluated the pharmacokinetic (PK) and pharmacodynamic (PD) interactions between EV and sodium glucose cotransporter‐2 inhibitors (SGLT2i) in...